SCWorx Corp. provides software solutions for the management of health care providers' foundational business applications in the United States. The company provides services related to repair, normalization, and interoperability of information, as well as big data analytics model that provides web portal for display, and reporting and analysis of the information contained within the data warehouse. It also offers various software solutions and services, such as virtualized item master file repair, expansion, and automation; electronic medical record management, a module that integrates the advanced data attributes created in the item master to the electronic medical records; charge description master management(CDM), a module, which assists healthcare providers by integrating the CDM data into the workflow of the hospitals purchasing systems; contract management, a module that assists healthcare providers to establish a contract management system and to provide care to patients; request for proposal automation solution; rebate management; ScanWorx, a mobile perioperative closed loop scanning solution; and data integration and warehousing, as well as solutions for integration of acquired businesses, which enable deployment of a virtual item master files. The company sells its solutions and services to hospitals and health systems through its distribution and reseller partnerships. In addition, it offers CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling rapid test kits for COVID-19; and personal protective equipment. SCWorx Corp. is based in New York, New York.
IPO Year: 2016
Exchange: NASDAQ
Website: scworx.com
10-Q - SCWorx Corp. (0001674227) (Filer)
8-K - SCWorx Corp. (0001674227) (Filer)
10-Q - SCWorx Corp. (0001674227) (Filer)
10-Q - SCWorx Corp. (0001674227) (Filer)
10-K - SCWorx Corp. (0001674227) (Filer)
8-K - SCWorx Corp. (0001674227) (Filer)
8-K - SCWorx Corp. (0001674227) (Filer)
8-K - SCWorx Corp. (0001674227) (Filer)
8-K - SCWorx Corp. (0001674227) (Filer)
8-K - SCWorx Corp. (0001674227) (Filer)
3 - SCWorx Corp. (0001674227) (Issuer)
3 - SCWorx Corp. (0001674227) (Issuer)
4 - SCWorx Corp. (0001674227) (Issuer)
4 - SCWorx Corp. (0001674227) (Issuer)
4 - SCWorx Corp. (0001674227) (Issuer)
3 - SCWorx Corp. (0001674227) (Issuer)
4 - SCWorx Corp. (0001674227) (Issuer)
4 - SCWorx Corp. (0001674227) (Issuer)
4 - SCWorx Corp. (0001674227) (Issuer)
4 - SCWorx Corp. (0001674227) (Issuer)
NEW YORK, N.Y., Nov. 20, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ:WORX) (the "Company"), a provider of data management services to healthcare providers, announced today that it has regained compliance with The Nasdaq Stock Market's ("Nasdaq") continued listing requirements regarding periodic reporting. On April 17, May 17, and August 19, 2024, Nasdaq notified the Company that it no longer met the Nasdaq's periodic filing requirement under Listing Rule 5250(c)(1) (the "Rule"). In a letter dated October 14, 2024, Nasdaq indicated that based on the September 24, October 10, and October 11, 2024, filing of the Company's Form 10-K for the year ended December 31, 2023, and Forms 10-Q for
New York, NY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp (the "Company"), on November 19th, 2024 completed an equity financing with institutional investors (the "Institutional Investors" or "Investors"). In connection with the funding, the Company sold an aggregate of 232,558 shares of common stock and warrants to purchase the same number of shares of common stock, for aggregate gross proceeds of $200,000. The Company will be registering for resale the shares of common stock and warrant shares with U.S. Securities and Exchange Commission (the "SEC"). SCWorx expects to use net proceeds from the financing for working capital and general corporate purposes to support its future growth.
NEW YORK, N.Y., Aug. 23, 2024 (GLOBE NEWSWIRE) -- On August 19, 2024, the Nasdaq Stock Market notified SCWorx Corp. (the "Company") that it has failed to satisfy a standard for continued listing, namely Nasdaq Listing Rule 5250(c)(1) (the "Rule), because the Company did not file its June 30, 2024 Quarterly Report on Form 10-Q by the due date of August 14, 2024 and because it remains delinquent in filing its Form 10-K for the period ended December 31, 2023 and its Form 10Q for the quarter ended March 31, 2024. As previously disclosed, due to the SEC's Order denying BF Borgers CPA PC ("BF Borgers") the privilege of appearing or practicing before the Commission as an accountant, on May 7
NEW YORK, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- On May 17, 2024, SCWorx Corp. (the "Company") received a further notice (the "Notice") from The Nasdaq Stock Market, LLC ("Nasdaq") indicating that, as a result of not having timely filed its Form 10-Q for the period ended March 31, 2024, and because it remains delinquent in filing its Form 10-K for the year ended December 31, 2023, the Company has failed to satisfy a standard for continued listing, namely Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic reports with the SEC. As previously disclosed, due to the SEC's Order denying BF Borgers CPA PC ("BF Borgers") the privilege of appearing or practic
NEW YORK, N.Y., April 23, 2024 (GLOBE NEWSWIRE) -- On April 17, 2024, SCWorx Corp. (the "Company") received a notice (the "Notice") from The Nasdaq Stock Market, LLC ("Nasdaq") indicating that, as a result of not having timely filed its Form 10-K for the period ended December 31, 2023 with the Securities and Exchange Commission ("SEC"), the Company has failed to satisfy a standard for continued listing, namely Nasdaq Listing Rule 5250(c)(1) , which requires timely filing of all required periodic reports with the SEC. According to the Notice, the Company has 60 calendar days to submit a plan to regain compliance. While the Company can provide no assurances as to timing, the Com
New York, NY, Oct. 23, 2023 (GLOBE NEWSWIRE) -- SCWorx Corp (the "Company" or "SCWorx")) (NASDAQ:WORX) is pleased to announce that on October 20, 2023 it entered into a letter of intent to acquire American Environmental Partners, Inc (Formerly American Energy Partners, Inc) ("American Environmental") (OTC:AEPT) (the "LOI"). The LOI sets forth the proposed terms and conditions pursuant to which the Company and American Environmental intend to effect a business combination, as a result of which American Environmental and the Company's healthcare data management business will each be conducted through wholly-owned subsidiaries of the Company ("Proposed Transaction"). The Com
New York, NY, Oct. 10, 2023 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ:WORX) announces the successful conclusion of its 2023 Annual Meeting of Stockholders (the "Meeting"). The Meeting yielded significant positive outcomes, instilling confidence in the Company amongst investors and stakeholders with shareholders embracing the reverse stock split and showing overwhelming support for the Company. Following the Meeting, the Company's Board of Directors (the "Board") approved a final ratio of 15-for-1 for the reverse stock split (the "Split"), which was within the parameters approved by the shareholders. The Split is expected to become effective at market open on October 11, 2023, pending conf
New York, NY, April 25, 2023 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ:WORX) today announced that it has signed another new healthcare provider for its SaaS data management service offering and Workday implementation assistance. This new hospital customer, headquartered in New York, is a non-profit academic healthcare provider with over 400 beds under management. In addition to the company's data management service offering the hospital will utilize SCWorx expertise and application functionality to assist with the hospital's Workday implementation. "SCWorx is providing this new customer with our Foundation data management platform. This platform is continuing to be recognized as
New York, NY, Jan. 30, 2023 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ:WORX) today announced that it has signed a new healthcare provider for the utilization of its recently launched SaaS service offering. SCWorx's new product offering continues to enable hospitals of all sizes to quickly and easily benefit from the SCWorx data platform. This new customer, headquartered in Texas, is a private healthcare provider with nearly 8,000 beds under management. SCWorx offers a technically advanced solution which has proven to be beneficial to all size hospitals that face difficult data management issues. "Healthcare providers are facing unprecedented challenges in this post-Covid era. SCWorx is
December 13, 2022 New York, Dec. 13, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp (NASDAQ:WORX) ("SCWorx" or the "Company"), a software-as-a-service company focused on data management for healthcare providers received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC ("Nasdaq") granting the Company's request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The Company now has until June 5, 2023 to meet the requirement. Nasdaq's extension notice has no immediate effect on the continued listing status of the Company's common stock on The Nasdaq Capital Market LL
SC 13G - SCWorx Corp. (0001674227) (Subject)
SC 13G/A - SCWorx Corp. (0001674227) (Subject)
New York, NY, Oct. 10, 2023 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ:WORX) announces the successful conclusion of its 2023 Annual Meeting of Stockholders (the "Meeting"). The Meeting yielded significant positive outcomes, instilling confidence in the Company amongst investors and stakeholders with shareholders embracing the reverse stock split and showing overwhelming support for the Company. Following the Meeting, the Company's Board of Directors (the "Board") approved a final ratio of 15-for-1 for the reverse stock split (the "Split"), which was within the parameters approved by the shareholders. The Split is expected to become effective at market open on October 11, 2023, pending conf
NEW YORK, N.Y., June 01, 2021 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ:WORX), a provider of data management services to healthcare providers, announced today that it has regained compliance with The Nasdaq Stock Market's ("Nasdaq") continued listing requirements regarding annual stockholder meetings and periodic reporting. In a letter dated May 25, 2021, Nasdaq indicated that SCWorx has regained compliance with its continued listing requirements for periodic reporting as a result of the filing of the Company's Annual Report on Form 10-K for the year ended December 31, 2020. In addition, the Company received a letter from Nasdaq on May 27, 2021 indicating that it has regained compliance wi
NEW YORK, NY, March 15, 2021 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ: WORX), a provider of data management services to healthcare providers, announced today its Board of Directors has appointed Alton Irby to serve as a board member, effective immediately. “We are pleased to welcome Mr. Irby to the SCWorx board of directors,” said Tim Hannibal, President and COO of SCWorx. “We believe that Mr. Irby’s long experience as an investment banker and advisor to many corporate boards in both the United States and Europe will bring valuable experience to SCWorx. In particular, his 17 year tenure as a senior member of the Board of McKesson Corporation gives him valuable experience in healthcare
- Reuters
Gainers Cue Health (NASDAQ:HLTH) stock moved upwards by 44.2% to $0.08 during Thursday's pre-market session. The market value of their outstanding shares is at $12.5 million. OneMedNet (NASDAQ:ONMD) stock increased by 42.05% to $2.77. The company's market cap stands at $66.0 million. Kintara Therapeutics (NASDAQ:KTRA) shares moved upwards by 33.23% to $0.36. The company's market cap stands at $20.0 million. Nexalin Technology (NASDAQ:NXL) stock rose 15.6% to $0.78. The market value of their outstanding shares is at $5.8 million. Gain Therapeutics (NASDAQ:GANX) shares moved upwards by 13.44% to $2.7. The market value of their outstanding shares is at $48.7 million. Jaguar Health (NASDAQ
Gainers Sharps Technology (NASDAQ:STSS) stock increased by 87.0% to $0.4 during Monday's after-market session. The company's market cap stands at $6.2 million. MorphoSys (NASDAQ:MOR) stock increased by 25.94% to $23.35. The market value of their outstanding shares is at $3.5 billion. Kintara Therapeutics (NASDAQ:KTRA) shares increased by 12.49% to $0.19. The market value of their outstanding shares is at $10.4 million. Mustang Bio (NASDAQ:MBIO) stock moved upwards by 11.91% to $0.23. The market value of their outstanding shares is at $2.9 million. icad (NASDAQ:ICAD) shares moved upwards by 10.75% to $1.75. The market value of their outstanding shares is at $46.4 million. Renalytix (NAS
Gainers Cue Health (NASDAQ:HLTH) stock moved upwards by 32.4% to $0.12 during Monday's pre-market session. The market value of their outstanding shares is at $19.8 million. SCWorx (NASDAQ:WORX) shares increased by 25.53% to $2.36. The company's market cap stands at $2.8 million. Innovative Eyewear (NASDAQ:LUCY) stock rose 19.62% to $0.22. The company's market cap stands at $3.8 million. Vaccinex (NASDAQ:VCNX) stock rose 17.86% to $6.07. The market value of their outstanding shares is at $9.6 million. Guardant Health (NASDAQ:GH) shares increased by 15.35% to $26.3. The company's market cap stands at $3.2 billion. Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 14.63% to $4.22. The co
Gainers Sharps Technology (NASDAQ:STSS) shares rose 50.5% to $0.32 during Friday's after-market session. The market value of their outstanding shares is at $5.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares increased by 9.75% to $2.25. The market value of their outstanding shares is at $3.2 million. Lucy Scientific Discovery (NASDAQ:LSDI) stock moved upwards by 6.89% to $0.93. The market value of their outstanding shares is at $1.6 million. Adial Pharmaceuticals (NASDAQ:ADIL) shares increased by 6.4% to $1.33. The company's market cap stands at $5.6 million. Aclaris Therapeutics (NASDAQ:ACRS) shares rose 5.4% to $1.17. The market value of their outstanding shares is at $83.3 mi
Shares of NetEase, Inc. (NASDAQ:NTES) fell during Friday's session after the company reported worse-than-expected first-quarter revenue. NetEase reported fiscal first-quarter 2024 revenue growth of 7.2% year-on-year to $3.72 billion (26.9 billion Chinese yuan), missing the analyst consensus estimate of $3.79 billion. The Chinese gaming player’s adjusted EPADS of $1.81 beat the analyst consensus estimate of $1.79, according to data from Benzinga Pro. NetEase shares declined 4% to $91.02 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Akanda Corp. (NASDAQ:AKAN) shares climbed 101% to $4.81. The international medical cannabis company implemented
Gainers Cue Health (NASDAQ:HLTH) shares moved upwards by 42.1% to $0.13 during Friday's pre-market session. The company's market cap stands at $21.3 million. Innovative Eyewear (NASDAQ:LUCY) stock rose 24.73% to $0.23. The market value of their outstanding shares is at $4.0 million. SCWorx (NASDAQ:WORX) shares increased by 17.02% to $2.2. The company's market cap stands at $2.6 million. Arcus Biosciences (NYSE:RCUS) stock rose 16.33% to $18.94. The company's market cap stands at $1.7 billion. Biora Therapeutics (NASDAQ:BIOR) stock moved upwards by 15.01% to $0.57. The market value of their outstanding shares is at $20.5 million. Jin Medical International (NASDAQ:ZJYL) shares moved upwa
On May 17, 2024, SCWorx Corp. (the "Company") received a further notice (the "Notice") from The Nasdaq Stock Market, LLC ("Nasdaq") indicating that, as a result of not having timely filed its Form 10-Q for the period ended March 31, 2024, and because it remains delinquent in filing its Form 10-K for the year ended December 31, 2023, the Company has failed to satisfy a standard for continued listing, namely Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic reports with the SEC.